Status:
COMPLETED
A Non Interventional Study To Asses The Safety, Effectiveness And Tolerability Of Quinapril (Acupil®) In An Indian Population
Lead Sponsor:
Pfizer
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
This is a prospective, non-interventional, non comparative drug study. The efficacy of Quinapril in Asian population has been evaluated, but specifically in Indian patients the data is sparse. Data in...
Eligibility Criteria
Inclusion
- Patients already on therapy with Acupil® for a minimum period of 4 weeks, Evidence of a personally signed and dated informed consent document
Exclusion
- Patients having a Week 0 visit blood pressure reading of more than 180/110 mm of Hg will not be eligible to participate in the study.
- Women of child bearing age, not willing to use contraceptives, will not be eligible for the study
- Women using oral contraceptives will also not be included in the study
- Patients who have received any drug other than Acupil® as the first prescribed antihypertensive would not be eligible for enrollment into the trial
- Patients having any complication at Week 0 visit which would require more thorough investigations or who required more than one anti-hypertensive drug at the time of initiation of their therapy will not be included in the study
- Patients having any contraindications as per the LPD of Acupil®
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
329 Patients enrolled
Trial Details
Trial ID
NCT00930722
Start Date
June 1 2009
End Date
June 1 2010
Last Update
May 4 2011
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Patna, Bihar, India, 01
2
Pfizer Investigational Site
Ahmedabad, Gujarat, India, 380 015
3
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 003
4
Pfizer Investigational Site
Bangalore, Karnataka, India, 560 051